Question and verified answers Bank
2026
**Purpose:** Original practice questions covering core advanced
pathophysiology concepts — disease mechanisms, compensatory responses,
and systems-based pathology. Each question includes the correct answer
and a teaching explanation so you can check *why* an answer is right, not
just *what* it is.
This is a study tool for building understanding, not a reproduction of
any specific school's exam.
---
## Cardiovascular System
**1. A patient with long-standing hypertension develops concentric left
ventricular hypertrophy. What is the primary physiologic driver of this
remodeling pattern?**
A) Volume overload causing eccentric hypertrophy
B) Pressure overload causing sarcomeres to add in parallel
C) Ischemia causing myocyte apoptosis
D) Valvular regurgitation causing chamber dilation
**Answer: B**
*Explanation:* Chronic pressure overload (as in hypertension or aortic
stenosis) causes myocytes to add sarcomeres in parallel, thickening the
ventricular wall without proportional chamber dilation — concentric
hypertrophy. Volume overload (e.g., mitral regurgitation) instead adds
sarcomeres in series, producing eccentric hypertrophy with chamber
dilation.
**2. In heart failure with reduced ejection fraction, activation of the
renin-angiotensin-aldosterone system (RAAS) initially compensates for
falling cardiac output. Over time, why does this same system worsen the
disease?**
A) It directly damages the pulmonary vasculature
B) Chronic angiotensin II and aldosterone promote myocardial fibrosis,
remodeling, and increased afterload
C) It suppresses sympathetic tone excessively
D) It causes hypokalemia that triggers arrhythmia exclusively
**Answer: B**
*Explanation:* RAAS activation raises blood pressure and preload acutely,
supporting perfusion. Chronically, angiotensin II promotes
vasoconstriction (increasing afterload) and both angiotensin II and
aldosterone drive cardiac fibrosis and maladaptive remodeling,
,accelerating the decline in pump function — the rationale for ACE
inhibitor/ARB and aldosterone antagonist therapy in heart failure.
**3. A patient presents with jugular venous distension, hepatomegaly, and
peripheral edema but clear lung fields. Which cardiac process best
explains this presentation?**
A) Left-sided heart failure
B) Right-sided heart failure
C) Acute mitral valve rupture
D) Pericardial tamponade with equalized pressures only
**Answer: B**
*Explanation:* Right-sided heart failure causes systemic venous
congestion — JVD, hepatomegaly, and dependent edema — because the right
ventricle cannot forward blood into the pulmonary circulation, backing
pressure into the systemic venous system. Clear lungs help distinguish it
from left-sided failure, where pulmonary congestion dominates.
**4. Which mechanism underlies the pathologic Q waves seen on ECG after a
transmural myocardial infarction?**
A) Reversible ischemia without cell death
B) Full-thickness myocardial necrosis eliminating electrical activity in
that region
C) Increased vagal tone
D) Atrial enlargement
**Answer: B**
*Explanation:* Transmural (full-thickness) infarction destroys myocardium
across the entire ventricular wall, so there's no viable tissue to
generate depolarization current in that region. The recording electrode
instead "sees through" the dead zone to opposite wall depolarization
moving away, producing a pathologic Q wave.
**5. A patient in septic shock has warm extremities, bounding pulses, and
hypotension despite fluid resuscitation. What is the primary hemodynamic
abnormality?**
A) Increased systemic vascular resistance
B) Profound vasodilation from inflammatory mediators reducing systemic
vascular resistance
C) Primary pump failure
D) Mechanical obstruction of venous return
**Answer: B**
*Explanation:* Septic shock is a distributive shock state. Inflammatory
mediators (nitric oxide, cytokines) cause widespread vasodilation and
capillary leak, dropping systemic vascular resistance. Cardiac output is
often initially preserved or elevated (warm shock), distinguishing it
from cardiogenic or hypovolemic shock where extremities are typically
cool.
---
## Respiratory System
, **6. A patient with COPD has chronic hypoxemia and develops secondary
polycythemia. What is the physiologic rationale?**
A) Chronic hypoxia increases erythropoietin production, stimulating RBC
production to improve oxygen-carrying capacity
B) Hypoxia directly damages the bone marrow, causing compensatory
overproduction
C) CO2 retention stimulates the spleen to release stored RBCs permanently
D) It is unrelated to oxygen levels and reflects chronic inflammation
alone
**Answer: A**
*Explanation:* Sustained hypoxemia is sensed by peritubular cells in the
kidney, which increase erythropoietin secretion. This drives bone marrow
RBC production to compensate for reduced oxygen delivery — an adaptive
but double-edged response, since resulting increased blood viscosity
raises the risk of thrombosis and pulmonary hypertension.
**7. In acute respiratory distress syndrome (ARDS), what is the primary
pathophysiologic defect?**
A) Airway bronchoconstriction
B) Diffuse alveolar-capillary membrane damage leading to increased
permeability and protein-rich pulmonary edema
C) Pulmonary embolism obstructing blood flow
D) Loss of elastic recoil in alveolar walls
**Answer: B**
*Explanation:* ARDS results from diffuse injury to the alveolar-capillary
membrane (from sepsis, aspiration, trauma, etc.), increasing permeability
and allowing protein-rich fluid to flood the alveoli. This impairs gas
exchange (refractory hypoxemia) and reduces lung compliance, distinct
from the airway-focused pathology of asthma or COPD.
**8. A patient with a large pulmonary embolism develops sudden dyspnea
and hypoxemia. What is the primary mechanism of the hypoxemia?**
A) Diffusion defect from alveolar fibrosis
B) Ventilation-perfusion (V/Q) mismatch — ventilated alveoli receive no
perfusion
C) Hypoventilation from respiratory muscle fatigue
D) Right-to-left intracardiac shunt
**Answer: B**
*Explanation:* A pulmonary embolism obstructs blood flow to a portion of
ventilated lung, creating dead space (high V/Q) in that region. Reflex
bronchoconstriction and surfactant dysfunction in the affected area, plus
redistribution of blood flow to other regions (worsening their V/Q
matching), produce the resulting hypoxemia.
**9. Why does a patient with chronic bronchitis often present with
cyanosis and a productive cough ("blue bloater" phenotype), in contrast
to emphysema's "pink puffer" pattern?**
A) Chronic bronchitis primarily destroys alveolar walls first
B) Airway inflammation and mucus hypersecretion cause V/Q mismatch with
significant hypoxemia and hypercapnia, while respiratory drive remains
relatively preserved, leading to less compensatory hyperventilation